Arrowhead Pharmaceuticals Hosts Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibro
AzurRx Begins Phase 2b Trial Testing MS1819 for Pancreatic Insufficiency in CF Patients


Smoking, Respiratory Issues, Older Age Raise Hospital Costs, Chinese Study Finds


Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis Bronc


World-first clinical trial raises hopes of new drug for chronic lung disease
The Multidisciplinary Team Improves Cystic Fibrosis Outcomes
Women With CF Use Combined Hormonal Contraceptives More Than Other Methods, Study Reports


Drying Does Not Clear Nebulizers of NTM Bacteria, Study Finds


CHMP Gives Positive Opinion to Vertex’s Triple Combination Therapy Kaftrio


Brensocatib prolongs time to first pulmonary exacerbation in patients with bronchiectasis

